What We Do

keyboard_arrow_down

Our Insights

keyboard_arrow_down

Who We Serve

keyboard_arrow_down

About Us

keyboard_arrow_down

Mental Health

is the "Cancer" of tomorrow

Mental health disorders remain the highest unmet medical need, surpassing cardiovascular disease, diabetes and cancer. Cumulative economic burden exceed 16 Trillion USD in direct and indirect costs. At Holmusk, we are addressing this problem by building the world's largest Real-World Evidence (RWE) platform for mental health to deliver clinical and regulatory grade evidence to all major stakeholders of the healthcare ecosystem.




Our proprietary technology is also harnessed to analyze real-world data across other chronic metabolic diseases including diabetes, cardiovascular disease, chronic kidney disease etc. By integrating our work on metabolic diseases with the mental health RWE platform we can generate even deeper insights. Our goal is to develop a system-wide integrated care model between mental and chronic health which makes access to RWE a reality of today, rather than a dream of tomorrow.

Data
Analytics

Proprietary in house analytical tools which work on real-world data to recognize disease progression and articulate personalized intervention strategies.

Learn More >

Speciality
EHR

Speciality Electronic Health Record (EHR) system and database built exclusively for neuroscience disorders to advance data-driven, decision-making in mental health practice and research.

Learn More >

Digital
Therapeutics

AI powered, human enabled patient facing digital intervention tools that promote behavior change.

Learn More >

Our Partners

Commercial

Academic

Government Institutions

News

The 5 Health Start-Ups You Need to Know About

March 7, 2019

CaregiverAsia and Holmusk Partner to Provide Real-time and Customised Home Care Solutions for Careseekers with Diabetes

January 22, 2019

Real-World Evidence – A Game Changer for Pharma

January 18, 2019

Holmusk Proudly Announces Residency at JLABS @ NYC

January 7, 2019

Holmusk Raises USD$9.75 Million in Pre-Series A Financing

September 25, 2018

Ascensia Announces Finalists For The Ascensia Diabetes Challenge Who Have The Potential To Revolutionize Type 2 Diabetes Management

April 3, 2018

Multi-Omic Data Analytics Collaboration Between the University of Oxford and Holmusk

October 2, 2017

Holmusk: Using Data to Improve Clinical Outcomes for Cardiovascular Disease in Singapore

April 6, 2017

Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner to Innovate Healthcare IT for Chronic Disease

March 27, 2017

Holmusk Showcases a Digital Diabetes Management Program (GlycoLeap) at World Innovation Summit for Health (WISH) in Doha, Qatar

November 22, 2016

Singapore Digital Health Company Launches New Smart Coach for Type 2 Diabetes

October 3, 2016

Holmusk to Acquire Rights in Behavioral Health Management System from Major National Academic Medical Center

November 1, 2015

Big Data Collaboration to Improve Chronic Disease Management

August 3, 2015